Dose consolidation may not be worth the trouble.
Sipkoff
Martin
M
D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D004358:Drug Therapy / Q000379:methods*; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D014481:United States